ATTR-CM Hospitalization Consequences | Attruby® (acoramidis)
ATTR-CM Hospitalization Consequences | Attruby® (acoram…
3 months ago
linkedin.com
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the First Near Complete TTR Stabilizer (=90%), Approved by the European Commission to Treat ATTR-CM
BridgeBio Pharma, Inc.: BEYONTTRA (acoramidis), the Fir…
10 months ago
finanznachrichten.de
94K views · 792 reactions | Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. Please see Important Safety Information at Attruby.com/#ISI for Attruby® (acoramidis) and Full Prescribing Information and Patient Information at Attruby.com/PI. | Morgan Freeman | Facebook
94K views · 792 reactions | Learn more about how Attruby can help …
22.6K views1 week ago
FacebookMorgan Freeman
BridgeBio Pharma, Inc.: First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study
BridgeBio Pharma, Inc.: First Participant Dosed with Acoramidi…
7 months ago
finanznachrichten.de
BridgeBio Pharma, Inc.: Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
BridgeBio Pharma, Inc.: Acoramidis Shows Statistically Significant Im…
9 months ago
finanznachrichten.de
Learn more about how Attruby can help adults with ATTR-cardiac amyloidosis. Please see Important Safety Information, Full Prescribing Information, and Patient Information at @attruby_pi. Morgan Freeman does not live with ATTR-CM. #SponsoredbyAttruby | Morgan Freeman
2:09
Learn more about how Attruby can help adults with ATTR-cardiac am…
450.4K views1 month ago
FacebookMorgan Freeman
BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Beat and Renewed Analyst Support
BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Bea…
1 week ago
YahooSimply Wall St
Brücke in neue Therapie: BridgeBio betritt den Herzmarkt
3 months ago
klamm.de
Impact of Attruby on serum TTR levels
1 month ago
linkedin.com
BridgeBio Pharma, Inc.: BridgeBio Shares Recurrent Event Analysis …
Sep 28, 2024
finanznachrichten.de
BridgeBio Pharma: ATTRibute-CM Study Fails To Meet Primary Endp…
Dec 27, 2021
nasdaq.com
The News That Could Stoke BridgeBio, Up 80% This Year
2 months ago
investors.com
0:40
New Breakthrough in Heart Failure Treatment: Acoramidis for ATTR-CM
1.2K viewsDec 5, 2024
YouTubeMUSC Health
1:01
Learn more about how Attruby can help adults with ATTR-cardiac am…
61 views1 month ago
YouTubeMorgan Freeman
BridgeBio Pharma, Inc.: BridgeBio Announces Commercial Progress…
11 months ago
finanznachrichten.de
0:59
Please see Important Safety Information at Attruby.com/#ISI fo…
57.2K views7 months ago
FacebookMorgan Freeman
Interactive Chart
2 weeks ago
zacks.com
BridgeBio's Acoramidis Cuts Risk Within Weeks In Rare Heart Condit…
2 months ago
aol.co.uk
Attruby TV Spot, 'A Diagnosis Doesn't Define You' Featuring Mor…
8 months ago
iSpot.tv
2:41
How the Attruby Digital Companion on Medisafe Can Help You Stay o…
71 views3 months ago
YouTubeAttruby™ (acoramidis)
Early Diagnosis of Transthyretin Amyloid Cardiomyopathy
4 months ago
medscape.com
1:51
How BridgeBio Transformed Compliance With Egnyte’s GxP Co…
36 views8 months ago
VimeoEgnyte
BridgeBio Pharma, Inc.: BridgeBio Pharma Announces U.S. Food an…
May 2, 2024
finanznachrichten.de
4:51
ATTRUBY - FDA NDA approval - 2024-11-22
191 viewsDec 11, 2024
YouTubeInside Drug Discovery
9:19
【BUY NOW!?】BridgeBio Pharma:Top Biotech Stocks to Wa…
133 views7 months ago
YouTubeBiotech Investing
BridgeBio Introduces - On Rare
62 views9 months ago
YouTubeBridgeBio Pharma
BridgeBio Pharma, Inc.: BridgeBio Announces Infigratinib Is the Firs…
Sep 17, 2024
finanznachrichten.de
LLNL and BridgeBio announce trials for supercomputing-discovered ca…
1 month ago
llnl.gov
1:49
BridgeBio Raised $135M to Fund 10 Drugs at Once—Here’s How
114 views5 months ago
YouTubeMelissa Bime
36:27
Bridgebio Genetic HypoPARA & ADH1
215 views11 months ago
YouTubeHypoPARAthyroidism Association
See more videos
Static thumbnail place holder